✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Accretion Pharmaceuticals Ltd.

ACCPL

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹63 Cr.
P/E
9.30

Accretion Pharmaceuticals Ltd.

  • Accretion Pharma.
  • Sakar Healthcare
  • Lincoln Pharma

FAQs on Accretion Pharmaceuticals Ltd. Shareprice

There is not enough historical data for the companies share price.

Accretion Pharma. is not expensive.
Latest PE of Accretion Pharma. is 9.3, while 3 year average PE is 10.5.
Also latest EV/EBITDA of Accretion Pharma. is 7.63 while 3yr average is 7.72.

View FAQ's On Business

Growth Table

  • Accretion Pharmaceuticals Ltd.
  • Sakar Healthcare
  • Lincoln Pharma

Balance Sheet

  • Accretion Pharmaceuticals Ltd.
  • Sakar Healthcare
  • Lincoln Pharma

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Accretion Pharmaceuticals Ltd.
  • Sakar Healthcare
  • Lincoln Pharma

Cash Flow

  • Accretion Pharmaceuticals Ltd.
  • Sakar Healthcare
  • Lincoln Pharma

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Accretion Pharmaceuticals Ltd.
  • Sakar Healthcare
  • Lincoln Pharma

Quarterly Results

  • Accretion Pharmaceuticals Ltd.
  • Sakar Healthcare
  • Lincoln Pharma

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Accretion Pharmaceuticals Ltd. Financials

Balance sheet of Accretion Pharma. is strong.
But short term working capital might become an issue for this company.

Yes, The net debt of Accretion Pharma. is increasing.
Latest net debt of Accretion Pharma. is ₹14.05 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹13.39 Crs.

Yes, profit is increasing.
The profit of Accretion Pharma. is ₹6.79 Crs for Mar 2025, ₹1.49 Crs for Mar 2024 and ₹0 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Accretion Pharma. latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Inventory, Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech